Search

Your search keyword '"Olopade OI"' showing total 639 results

Search Constraints

Start Over You searched for: Author "Olopade OI" Remove constraint Author: "Olopade OI"
639 results on '"Olopade OI"'

Search Results

1. Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers

2. Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers

3. Parity and breastfeeding are protective against breast cancer in Nigerian women

4. REPORT on the Fifth International Workshop on Chromosome 9 held at Eynsham, Oxfordshire, UK, September 4–6, 1996

5. Report on the 1996 International chromosome 9 workshop

6. Polygenic risk modeling for prediction of epithelial ovarian cancer risk (vol 30, pg 349, 2021)

7. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

8. Pharmacogenomics‐Based Point‐of‐Care Clinical Decision Support Significantly Alters Drug Prescribing

9. Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers

10. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

11. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (vol 12, 1078, 2021)

12. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

13. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

14. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

15. Shared heritability and functional enrichment across six solid cancers

16. The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries

17. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

19. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

20. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

22. Abstract P5-19-04: Psychosocial impact of a multi-modality surveillance program for women at high-risk for breast cancer

24. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

25. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

26. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

27. Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing

29. Abstract P5-09-02: Breast cancer risk prediction using a polygenic risk score in women of African ancestry: Findings from GWAS in breast cancer in the African diaspora

30. Abstract PD8-05: Comparative analysis of the genomic landscape of breast cancers from women of African and European ancestry

31. Abstract P1-05-11: Comprehensive comparison of breast cancer molecular portraits by African and European ancestry in the cancer genome atlas

32. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

33. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

34. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

35. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

36. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

37. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

38. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

39. Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers

40. DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

41. Abstract P6-04-05: Genotype-phenotype classification of triple negative breast cancers (TNBC) in women of African descent using the PAM50 NanoString platform and genomic data

43. Abstract P6-03-17: Genomic landscape of breast cancers from women of African ancestry across the diaspora

44. Abstract P3-07-48: Prediction of complete pathologic response to veliparib/carboplatin plus standard neoadjuvant therapy in HER2 negative breast cancer: Exploratory protein pathway marker results from the I-SPY 2 trial

45. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

46. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

47. Mutation Spectrum and Risk of Colorectal Cancer in African American Families with Lynch Syndrome

48. The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation

49. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

50. Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation

Catalog

Books, media, physical & digital resources